Acute Lymphoblastic Leukemia ALL Cytogenetics Panel Test
Comprehensive Genetic Analysis for Precise Leukemia Diagnosis
The Acute Lymphoblastic Leukemia ALL Cytogenetics Panel represents a cutting-edge diagnostic approach that revolutionizes how we understand and treat this aggressive blood cancer. This comprehensive genetic analysis provides hematologists with critical information about the chromosomal abnormalities driving leukemia development, enabling personalized treatment strategies that significantly improve patient outcomes.
What This Advanced Test Measures and Detects
Our ALL Cytogenetics Panel employs sophisticated laboratory techniques to identify specific genetic markers that define leukemia subtypes and predict treatment response:
- BCR/ABL Fusion (Philadelphia Chromosome): Detects the t(9;22) translocation that creates the BCR-ABL fusion gene, associated with poor prognosis and requiring targeted therapy
- MLL Gene Rearrangements: Identifies abnormalities involving the 11q23 region, particularly important in infant ALL and associated with treatment resistance
- TEL/AML1 Fusion: Screens for the t(12;21) translocation, typically associated with favorable prognosis in pediatric ALL
- Comprehensive Chromosome Analysis: Examines the complete chromosomal landscape for additional abnormalities that may impact treatment decisions
Who Should Consider This Essential Diagnostic Test
This comprehensive cytogenetics panel is recommended for individuals presenting with symptoms suggestive of acute lymphoblastic leukemia or those with confirmed ALL diagnosis requiring detailed genetic characterization:
- Patients exhibiting unexplained fatigue, persistent fever, or frequent infections
- Individuals with unexplained bruising, bleeding tendencies, or petechiae
- Patients experiencing bone pain, joint discomfort, or swollen lymph nodes
- Those with abnormal complete blood count results showing elevated white blood cells
- Newly diagnosed ALL patients requiring comprehensive genetic profiling
- Patients with suspected relapse or treatment-resistant leukemia
Significant Benefits of Comprehensive Genetic Testing
Undergoing the ALL Cytogenetics Panel provides numerous advantages for both patients and healthcare providers:
- Precise Diagnosis: Identifies specific genetic subtypes of ALL, enabling accurate classification beyond standard morphological assessment
- Prognostic Stratification: Determines disease aggressiveness and likely treatment response based on genetic markers
- Personalized Treatment Planning: Guides selection of targeted therapies, chemotherapy intensity, and stem cell transplantation decisions
- Minimal Residual Disease Monitoring: Establishes baseline genetic markers for ongoing treatment response assessment
- Family Counseling: Provides information about genetic predisposition in certain ALL subtypes
Understanding Your Test Results
Our comprehensive report provides detailed interpretation of your genetic findings:
- Normal Results: No detectable chromosomal abnormalities, suggesting standard-risk ALL requiring conventional treatment approaches
- Philadelphia Chromosome Positive: Indicates high-risk disease requiring tyrosine kinase inhibitor therapy in addition to chemotherapy
- MLL Rearrangements: Suggests aggressive disease biology, often necessitating intensified treatment protocols
- TEL/AML1 Fusion: Typically associated with favorable prognosis and standard treatment regimens
- Complex Karyotype: Multiple chromosomal abnormalities indicating high-risk disease requiring specialized management
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $676 |
Turnaround Time: Sample accepted daily by 4 pm; Reports delivered within 4 working days
Sample Requirements: 8 mL (6 mL minimum) whole blood from 2 Green Top (Sodium Heparin) tubes AND 4 mL (2 mL minimum) Bone Marrow from 1 Green Top (Sodium Heparin) tube. Ship at 18-22°C. DO NOT FREEZE. Duly filled Chromosome and FISH analysis Requisition form (Form 17) is mandatory.
Nationwide Accessibility and Expert Support
We maintain comprehensive testing facilities across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories ensures consistent, high-quality results regardless of your location.
Our team of board-certified hematologists and genetic specialists provides comprehensive support throughout the testing process, from sample collection to result interpretation and treatment planning.
Take Control of Your Leukemia Diagnosis Today
Don’t leave your leukemia diagnosis to chance. The ALL Cytogenetics Panel provides the genetic clarity needed for optimal treatment decisions. Our advanced testing methodology combines the precision of FISH technology with the comprehensive assessment of conventional karyotyping, delivering unparalleled diagnostic accuracy.
Ready to schedule your test? Contact our genetic counseling team at +1(267) 388-9828 or book your appointment online. Take the first step toward personalized leukemia management with comprehensive genetic insights.